1 In this study, we have shown for the first time that BAP1 has
2 In this study, we have shown for the first time that both PD-
3 In this study, we have shown in a series of dogs with cancer
4 In this study, we have shown in normal human fibroblasts that
5 In this study, we have shown that adenovirus-expressing TNFSF
6 In this study, we have shown that antibodies raised against a
7 In this study, we have shown that deletion of either nrdHEKF
8 In this study, we have shown that due to the site-specific Ly
9 In this study, we have shown that E1A enhanced acetylation of
10 In this study, we have shown that EAE disease initiation and
11 In this study, we have shown that erythropoietin (Epo) activa
12 In this study, we have shown that FAK is highly phosphorylate
13 In this study, we have shown that familial medullary thyroid
14 In this study, we have shown that FAPP2, a PI4P effector and
15 In this study, we have shown that FH-deficient cells and tumo
16 In this study, we have shown that homozygous deletion of Nf1,
17 In this study, we have shown that Hsp70 integrates into artif
18 In this study, we have shown that intermolecular distance con
19 In this study, we have shown that it is possible to disrupt s
20 In this study, we have shown that Ldp27(-/-) parasites do not
21 In this study, we have shown that metabolic and cancer-causin
22 In this study, we have shown that Mx can incorporate the UspA
23 In this study, we have shown that overexpression of S100P led
24 In this study, we have shown that p38 mitogen-activated prote
25 In this study, we have shown that PD 0332991 (PD), an FDA-app
26 In this study, we have shown that pharmacological inhibition
27 In this study, we have shown that recombinant BH1999 from Bac
28 In this study, we have shown that rFnbA can act as a substrat
29 In this study, we have shown that serum response factor (SRF)
30 In this study, we have shown that soluble HIV-1 Vpr inhibits
31 In this study, we have shown that supernatants from PTx-treat
32 In this study, we have shown that T2R gene expression in both
33 In this study, we have shown that tau levels are reduced thro
34 In this study, we have shown that the altered receptor specif
35 In this study, we have shown that the anti-inflammatory cytok
36 In this study, we have shown that the histone acetylation sta
37 In this study, we have shown that the human homolog of Claspi
38 In this study, we have shown that the juxtamembrane region of
39 In this study, we have shown that the muscle-specific microRN
40 In this study, we have shown that the proinflammatory cytokin
41 In this study, we have shown that the prolactin-activated tyr
42 In this study, we have shown that the RTK human epidermal gro
43 In this study, we have shown that this cleavage results in a
44 In this study, we have shown that transduction of TAT-ARCL31F
45 In this study, we have shown that treatment of rat islets wit
46 In this study, we have shown that TSG-6 inhibits chemokine-st
47 In this study, we have shown that, via nicotinic acetylcholin
48 In this study, we have shown the importance of Bax and Bak in
49 In this study, we have shown the possible role of different a
50 In this study, we have shown using surface plasmon resonance